Your browser doesn't support javascript.
loading
Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
Mirna, Moritz; Holnthoner, Mario; Topf, Albert; Jirak, Peter; Fejzic, Dzeneta; Paar, Vera; Kellermair, Jörg; Blessberger, Hermann; Reiter, Christian; Kammler, Jürgen; Motloch, Lukas J; Jung, Christian; Kretzschmar, Daniel; Franz, Marcus; Alushi, Brunilda; Lauten, Alexander; Hoppe, Uta C; Steinwender, Clemens; Lichtenauer, Michael.
Afiliação
  • Mirna M; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Holnthoner M; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Topf A; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Jirak P; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Fejzic D; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Paar V; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Kellermair J; Department of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Blessberger H; Department of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Reiter C; Department of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Kammler J; Department of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Motloch LJ; Paracelsus Medical University of Salzburg, Linz, Austria.
  • Jung C; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Kretzschmar D; Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Duesseldorf, Dusseldorf, Germany.
  • Franz M; Department of Cardiology, Clinic of Internal Medicine I, Universitätsherzzentrum Thüringen, Friedrich Schiller University Jena, Jena, Germany.
  • Alushi B; Department of Cardiology, Clinic of Internal Medicine I, Universitätsherzzentrum Thüringen, Friedrich Schiller University Jena, Jena, Germany.
  • Lauten A; Department of General and Interventional Cardiology and Rhythmology, Helios Clinic, Erfurt, Germany.
  • Hoppe UC; Department of General and Interventional Cardiology and Rhythmology, Helios Clinic, Erfurt, Germany.
  • Steinwender C; Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
  • Lichtenauer M; Department of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
J Clin Lab Anal ; 35(11): e23977, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34562276
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Substituição da Valva Aórtica Transcateter Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Substituição da Valva Aórtica Transcateter Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article